Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omeros Corp (OMER)

Omeros Corp (OMER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 838,038
  • Shares Outstanding, K 70,900
  • Annual Sales, $ 0 K
  • Annual Income, $ -156,820 K
  • EBIT $ -129 M
  • EBITDA $ -127 M
  • 60-Month Beta 2.44
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 66.52% (-1.16%)
  • Historical Volatility 179.43%
  • IV Percentile 1%
  • IV Rank 2.81%
  • IV High 355.15% on 05/16/25
  • IV Low 58.19% on 02/13/25
  • Expected Move (DTE 15) 1.28 (11.08%)
  • Put/Call Vol Ratio 0.48
  • Today's Volume 1,033
  • Volume Avg (30-Day) 5,823
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 68,041
  • Open Int (30-Day) 104,653
  • Expected Range 10.24 to 12.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.55
  • Number of Estimates 1
  • High Estimate -0.55
  • Low Estimate -0.55
  • Prior Year -0.63
  • Growth Rate Est. (year over year) +12.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.30 +1.86%
on 02/04/26
16.39 -29.77%
on 01/05/26
-4.87 (-29.73%)
since 01/02/26
3-Month
6.24 +84.46%
on 11/13/25
17.65 -34.79%
on 12/24/25
+4.78 (+71.03%)
since 11/04/25
52-Week
2.95 +290.17%
on 07/01/25
17.65 -34.79%
on 12/24/25
+2.38 (+26.07%)
since 02/04/25

Most Recent Stories

More News
Omeros Announces First Commercial Sales of YARTEMLEA®

— Initial Orders Received and Fulfilled from Multiple Transplant Centers, with YARTEMLEA Now Administered to Both Adult and Pediatric Patients with TA-TMA —

OMER : 11.51 (-2.62%)
Omeros Announces New Date for YARTEMLEA® Approval Conference Call

— Omeros to Host Conference Call Wednesday, January 7, 2026 at 4:30 p.m. ET —

OMER : 11.51 (-2.62%)
FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA

– Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET –   First and only approved option: YARTEMLEA ®...

OMER : 11.51 (-2.62%)
Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906)

Omeros Corporation (Nasdaq: OMER) today announced the closing of the asset sale and licensing transaction between Omeros and Novo Nordisk for the candidate drug zaltenibart (formerly OMS906). Zaltenibart...

OMER : 11.51 (-2.62%)
Omeros: Q3 Earnings Snapshot

Omeros: Q3 Earnings Snapshot

OMER : 11.51 (-2.62%)
Omeros Corporation Reports Third Quarter 2025 Financial Results

– Conference Call Today at 4:30 p.m. ET

OMER : 11.51 (-2.62%)
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025

Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter ended September 30, 2025, on Thursday, November 13, 2025, after the market closes. Omeros...

OMER : 11.51 (-2.62%)
Breakout Momentum Plays You Need to Know About

Three stocks may draw the attention of momentum investors—QURE spiked in September, OMER in October, and SDST has almost 1,000% in upside potential.

QURE : 26.65 (-4.14%)
SDST : 3.83 (-2.79%)
NVO : 47.19 (-6.18%)
OGE : 43.65 (+0.79%)
OMER : 11.51 (-2.62%)
Breakout Momentum Plays You Need to Know About

Three stocks may draw the attention of momentum investors—QURE spiked in September, OMER in October, and SDST has almost 1,000% in upside potential.

QURE : 26.65 (-4.14%)
SDST : 3.83 (-2.79%)
NVO : 47.19 (-6.18%)
OGE : 43.65 (+0.79%)
OMER : 11.51 (-2.62%)
Needham Sticks to Its Hold Rating for Omeros (OMER)

In a report released today, Serge Belanger from Needham maintained a Hold rating on Omeros. The company’s shares opened today at $11.59.Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

OMER : 11.51 (-2.62%)

Business Summary

Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM)...

See More

Key Turning Points

3rd Resistance Point 12.54
2nd Resistance Point 12.25
1st Resistance Point 11.88
Last Price 11.51
1st Support Level 11.22
2nd Support Level 10.93
3rd Support Level 10.56

See More

52-Week High 17.65
Fibonacci 61.8% 12.03
Last Price 11.51
Fibonacci 50% 10.30
Fibonacci 38.2% 8.57
52-Week Low 2.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar